Mutant IDH1 Enhances the Production of 2-Hydroxyglutarate Due to Its Kinetic Mechanism
详细信息 查看全文
- 作者：Alan R. Rendina ; Beth Pietrak ; Angela Smallwood ; Huizhen Zhao ; Hongwei Qi ; Chad Quinn ; Nicholas D. Adams ; Nestor Concha ; Chaya Duraiswami ; Sara H. Thrall ; Sharon Sweitzer ; Benjamin Schwartz
- 刊名：Biochemistry
- 出版年：2013
- 出版时间：July 2, 2013
- 年：2013
- 卷：52
- 期：26
- 页码：4563-4577
- 全文大小：710K
- 年卷期：v.52,no.26(July 2, 2013)
- ISSN：1520-4995
文摘
The human, cytosolic enzyme isocitrate dehydrogenase 1 (IDH1) reversibly converts isocitrate to 伪-ketoglutarate (伪KG). Cancer-associated somatic mutations in IDH1 result in a loss of this normal function but a gain in a new or neomorphic ability to convert 伪KG to the oncometabolite 2-hydroxyglutarate (2HG). To improve our understanding of the basis for this phenomenon, we have conducted a detailed kinetic study of wild-type IDH1 as well as the known 2HG-producing clinical R132H and G97D mutants and mechanistic Y139D and (newly described) G97N mutants. In the reductive direction of the normal reaction (伪KG to isocitrate), dead-end inhibition studies suggest that wild-type IDH1 goes through a random sequential mechanism, similar to previous reports on related mammalian IDH enzymes. However, analogous experiments studying the reductive neomorphic reaction (伪KG to 2HG) with the mutant forms of IDH1 are more consistent with an ordered sequential mechanism, with NADPH binding before 伪KG. This result was further confirmed by primary kinetic isotope effects for which saturating with 伪KG greatly reduced the observed isotope effect on D(V/K)NADPH. For the mutant IDH1 enzyme, the change in mechanism was consistently associated with reduced efficiencies in the use of 伪KG as a substrate and enhanced efficiencies using NADPH as a substrate. We propose that the sum of these kinetic changes allows the mutant IDH1 enzymes to reductively trap 伪KG directly into 2HG, rather than allowing it to react with carbon dioxide and form isocitrate, as occurs in the wild-type enzyme.